The authors examine the epidemiology, pathogenesis, clinical expression, and differential diagnosis of Behçet’s syndrome, as well as targeted therapeutics.

The Behcet's disease current activity form (BDCAF) currently constitutes the best and easiest-to-use tool for disease activity estimation with an acceptable interobserver reliability for general ...

Behçet's disease is a complex, multisystem inflammatory disorder characterised by recurrent mucocutaneous lesions, ocular involvement, and vascular, neurological, and gastrointestinal ...

Patients with severe Behçet’s syndrome who received infliximab demonstrated better odds of achieving complete response at 22 weeks compared with those who used cyclophosphamide, according to ...